American Society of Hematology

SHERPA: Blue

People

  1. Curran
    Curran
  2. Giralt
    Giralt
  3. McCall
    McCall
  4. Moskowitz
    Moskowitz
  5. Perales
    Perales
  6. Ponce
    Ponce
  7. Scaradavou
    Scaradavou
  8. Yahalom
    Yahalom
  9. Bernal
    Bernal
  10. Casson
    Casson

Groups

  1. Advanced Practice Providers (6)
  2. Center for Hematologic Malignancies (6)
  3. Department of Medicine (6)
  4. Hematologic Malignancies, Division of (5)
  5. Nursing (5)
  6. Bone Marrow Transplant (4)
  7. Survivorship Research (4)
  8. GSK Faculty (3)
  9. Pediatrics, Department of (3)
  10. Radiation Oncology, Department of (3)
Search Within
  1. "Advanced Practice Providers"
  2. "Center for Hematologic Malignancies"
  3. "Blood"
  4. "2015"
Formats
  1. Meeting Abstract (6)
Groups
  1. Advanced Practice Providers (6)
  2. Center for Hematologic Malignancies (6)
  3. Department of Medicine (6)
  4. Hematologic Malignancies, Division of (5)
  5. Nursing (5)
  6. Bone Marrow Transplant (4)

More Groups

People
  1. Alison Moskowitz (2)
  2. Andromachi Scaradavou (2)
  3. Craig Moskowitz (2)
  4. Craig Sauter (2)
  5. Doris Ponce (2)
  6. Joachim Yahalom (2)

More People

Years
  1. 2015 (6)
Publications
  1. Blood (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective evaluation of cord blood (CB) & haplo-identical donor availability reveals compromised donor access for both graft types in minorities and high rates of failure to clear haplo donors in adult patients
    Meeting Abstract

    Kosuri, S.; Wolff, T. F.; Byam, C.; Lauer, E.; Yoo, Y.; Perales, M. A.; Giralt, S. A.; Scaradavou, A.; Ponce, D. M.; Barker, J. N.
    Blood (2015)

    Fulltext@MSK | Save
  • T-cell depleted peripheral blood stem cell (TCD-PBSC) transplants secure consistent engraftment with low risk of acute or chronic Gvhd and favorable disease free survival (DFS) and overall survival (OS) for pediatric patients (<21 years) with AML in CR1 or CR2 or MDS including tMDS/AML
    Meeting Abstract

    Kernan, N. A.; Boulad, F.; Prockop, S.; Wolden, S.; Scaradavou, A.; Kobos, R.; Lehrman, R.; Klein, E.; Curran, K. J.; Hasan, A. N.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Low dose unfractionated heparin (UFH) prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome (SOS) in adult allogeneic stem cell transplant (HSCT) recipients
    Meeting Abstract

    Bhatt, V.; Palazzo, M.; Kilroy, K.; Hilden, P.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H. R.; Chung, D. J.; Dahi, P. B.; Hsu, K. C.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Risk factors predicting outcomes for primary refractory Hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Bantilan, K. S.; Verwys, S. L.; McCall, S. J.; Yahalom, J.; Matasar, M. J.; Moskowitz, A. J.; Moskowitz, C. H.
    Blood (2015)

    Fulltext@MSK | Save
  • Implications of minimal residual disease negative complete remission (MRD-CR) and allogeneic stem cell transplant on safety and clinical outcome of CD19 targeted 19-28z CAR modified T cells in adult patients with relapsed, refractory B-cell ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Purdon, T.; Halton, E.; Wang, Y.; Curran, K. J.; Sauter, C. S.; Sadelain, M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • TARC predicts PET-normalization and event free surival in relapsed/refractory Hodgkin lymphoma patients treated with brentuximab vedotin
    Meeting Abstract

    Moskowitz, A. J.; Cho, S.; Fleisher, M.; Woo, K. M.; Zhang, Z. G.; Fox, S.; McCall, S. J.; Schoder, H.; Yahalom, J.; Moskowitz, C. H.
    Blood (2015)

    Fulltext@MSK | Save